🎁 Black Friday: up to 50% off of annual plans
Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China flag China · Delayed Price · Currency is CNY
26.38
-0.12 (-0.45%)
Nov 20, 2026, 3:00 PM CST

SHA:603882 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
5,3095,4456,6277,72614,52911,304
Other Revenue
585.66585.66562.98813.43946.76639.52
5,8956,0307,1908,54015,47611,943
Revenue Growth
-3.50%-16.12%-15.81%-44.82%29.58%44.88%
Cost of Revenue
3,7633,9354,8075,4258,8026,295
Gross Profit
2,1322,0952,3833,1156,6745,648
Selling, General & Admin
1,4681,5271,5291,7302,5062,323
Research & Development
323.93341.28400.47467.14632.62517.93
Other Operating Expenses
35.3513.9415.9114.9114.7511.71
Operating Expenses
1,7202,2532,5642,7003,4092,924
Operating Income
412.43-157.53-180.92414.933,2662,724
Interest Expense
-12.21-14.68-18.43-20.39-23.65-27.55
Interest & Investment Income
19.1124.3523.48288.3630.421.53
Currency Exchange Gain (Loss)
000.2-0.69.14-1.46
Other Non Operating Income (Expenses)
16.48-2.57-2.7-2.95-3.91-2.54
EBT Excluding Unusual Items
435.82-150.43-178.37679.353,2782,714
Impairment of Goodwill
-10.15-10.15----
Gain (Loss) on Sale of Investments
-16.57-3.63-140.82--10.8-7.29
Gain (Loss) on Sale of Assets
2.431.92-143.59-7.572.97-10.11
Asset Writedown
-0.02-----
Other Unusual Items
-21.98-19.3224.1468.5150.6450.87
Pretax Income
389.52-181.61-438.65740.293,3212,748
Income Tax Expense
70.07-3.01-23.94103.38475.72384.05
Earnings From Continuing Operations
319.45-178.6-414.7636.912,8452,364
Minority Interest in Earnings
-39.545.3633.466.47-90.22-143.87
Net Income
279.92-173.24-381.24643.382,7552,220
Net Income to Common
279.92-173.24-381.24643.382,7552,220
Net Income Growth
----76.64%24.11%47.02%
Shares Outstanding (Basic)
463468465466466462
Shares Outstanding (Diluted)
463468465466467466
Shares Change
-0.29%0.71%-0.28%-0.15%0.13%1.00%
EPS (Basic)
0.60-0.37-0.821.385.914.80
EPS (Diluted)
0.60-0.37-0.821.385.904.76
EPS Growth
----76.61%23.95%45.57%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
655.1778.55459.99516.071,1071,136
Free Cash Flow Per Share
1.421.660.991.112.372.44
Dividend Per Share
0.8800.8800.8800.8801.7801.280
Dividend Growth
0%0%0%-50.56%39.06%289.06%
Gross Margin
36.17%34.74%33.15%36.48%43.13%47.29%
Operating Margin
7.00%-2.61%-2.52%4.86%21.10%22.81%
Profit Margin
4.75%-2.87%-5.30%7.53%17.80%18.58%
Free Cash Flow Margin
11.11%12.91%6.40%6.04%7.16%9.51%
EBITDA
633.58159.65264.29866.663,6793,056
EBITDA Margin
10.75%2.65%3.68%10.15%23.77%25.59%
D&A For EBITDA
221.15317.18445.21451.73412.85331.56
EBIT
412.43-157.53-180.92414.933,2662,724
EBIT Margin
7.00%-2.61%-2.52%4.86%21.10%22.81%
Effective Tax Rate
17.99%--13.96%14.33%13.98%
Revenue as Reported
5,8956,0307,1908,54015,47611,943
Advertising Expenses
-3.540.762.163.293.16